| Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein–protein interaction module N Yim, SW Ryu, K Choi, KR Lee, S Lee, H Choi, J Kim, MR Shaker, W Sun, ... Nature communications 7 (1), 1-9, 2016 | 507 | 2016 |
| Mesenchymal stem cell‐derived extracellular vesicles as therapeutics and as a drug delivery platform G Baek*, H Choi*, Y Kim, HC Lee, C Choi Stem cells translational medicine 8 (9), 880-886, 2019 | 176 | 2019 |
| Exosome-based delivery of super-repressor IκBα relieves sepsis-associated organ damage and mortality H Choi, Y Kim, A Mirzaaghasi, J Heo, YN Kim, JH Shin, S Kim, NH Kim, ... Science advances 6 (15), eaaz6980, 2020 | 157 | 2020 |
| Biodistribution of exosomes and engineering strategies for targeted delivery of therapeutic exosomes H Choi, Y Choi, HY Yim, A Mirzaaghasi, JK Yoo, C Choi Tissue engineering and regenerative medicine 18 (4), 499-511, 2021 | 143 | 2021 |
| Manufacturing therapeutic exosomes: from bench to industry SH Ahn, SW Ryu, H Choi, S You, J Park, C Choi Molecules and cells 45 (5), 284-290, 2022 | 64 | 2022 |
| Strategies for targeted delivery of exosomes to the brain: advantages and challenges H Choi, K Choi, DH Kim, BK Oh, H Yim, S Jo, C Choi Pharmaceutics 14 (3), 672, 2022 | 47 | 2022 |
| Roles of Type I and III Interferons in COVID-19 H Choi, EC Shin Yonsei medical journal 62 (5), 381, 2021 | 30 | 2021 |
| Targeted delivery of exosomes armed with anti-cancer therapeutics H Choi, H Yim, C Park, SH Ahn, Y Ahn, A Lee, H Yang, C Choi Membranes 12 (1), 85, 2022 | 26 | 2022 |
| Quantitative Biodistribution and Pharmacokinetics Study of GMP-Grade Exosomes Labeled with 89Zr Radioisotope in Mice and Rats H Choi, MY Kim, DH Kim, H Yun, BK Oh, SB Kim, IH Song, HS Park, ... Pharmaceutics 14 (6), 1118, 2022 | 18 | 2022 |
| Hyper-inflammatory responses in COVID-19 and anti-inflammatory therapeutic approaches H Choi, EC Shin BMB reports 55 (1), 11, 2022 | 12 | 2022 |
| Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein interaction module. Nat Commun. 2016; 7: 12277 N Yim, SW Ryu, K Choi, KR Lee, S Lee, H Choi, J Kim, MR Shaker, W Sun, ... Eur J Pharm Biopharm 109, 184-93, 2016 | 8 | 2016 |
| Smartphone use at night affects melatonin secretion, body temperature, and heart rate N Na, H Choi, KA Jeong, K Choi, K Choi, C Choi, HJ Suk Science of Emotion and Sensibility 20 (4), 135-142, 2017 | 7 | 2017 |
| Exosome-based delivery of glucocerebrosidase lysosomal enzyme for treatment of Gaucher disease K Choi, H Choi, N Yim, SW Ryu, C Choi Molecular Genetics and Metabolism 123 (2), S31-S32, 2018 | 6 | 2018 |
| Compositions containing protein loaded exosome and methods for preparing and delivering the same C Chulhee, YIM Nambin, W Do Heo, RYU Seung-Wook, C Hojun, ... US Patent 10,702,581, 2020 | 3 | 2020 |
| Exosomes for target specific delivery and methods for preparing and delivering the same C Chulhee, YIM Nambin, C Hojun, C Kyungsun, RYU Seung-Wook US Patent App. 16/639,740, 2020 | 3 | 2020 |
| Diffusing protein binders to intrinsically disordered proteins C Liu*, K Wu*, H Choi*, H Han, X Zhang, JL Watson, S Shijo, AK Bera, ... bioRxiv, 2024.07.16.603789, 2024 | 2 | 2024 |
| Exploring the clinical transition of engineered exosomes designed for intracellular delivery of therapeutic proteins M Kim, H Choi, DJ Jang, HJ Kim, Y Sub, HY Gee, C Choi Stem Cells Translational Medicine, szae027, 2024 | 2 | 2024 |
| Exosome-mediated delivery of active glucocerebrosidase to Gaucher model cells H Choi, K Choi, C Choi Molecular Genetics and Metabolism 126 (2), S38-S39, 2019 | 2 | 2019 |
| Efficient and rapid cellular delivery of bioactive proteins using EXPLOR: exosomes engineered for protein loading via optically reversible protein-protein interaction N Yim, SW Ryu, K Choi, KR Lee, S Lee, H Choi, J Park, D Kim, W Heo, ... Cancer Research 76 (14_Supplement), 2167-2167, 2016 | 2 | 2016 |
| Compositions containing protein loaded exosome and methods for preparing and delivering the same C Chulhee, YIM Nambin, W Do Heo, RYU Seung-Wook, C Hojun, ... US Patent 11,872,193, 2024 | 1 | 2024 |
Chulhee Choi, MD, PhDCEO, ILIAS Biologics, Inc在 iliasbio.com 的电子邮件经过验证
